Search
Patexia Community
News and Analysis

Our Members

All »
salah moawad
Kun-Bin Hsieh
MUHAMAD AZMAN MISKAM
Koon Keung Tsang
mahan amiri
Mikk Putk
Jessie S
Amirhossein Yousefi
Amir Ayatollahi
Bharat Ram Ambati
yariv s
pradeep kumar
alind dubey
Sunil Gupta
Mehdi Sadaghdar

Innovation, Technology, and IP News

Major Med Device Product Developer GE HealthCare Collaborating with Healthcare Providers

Written by: Kregg Koch For good reasons, including product safety, quality assurance, development of delivery procedures and instructions, it has been a common practice for medical...

Fresh From the Bench: Latest Precedential Patent Cases

CASE OF THE WEEK Baxalta Inc. v. Genentech, Inc., Appeal No. 22-1461 (Fed. Cir. Sept. 20, 2023) Our Case of the Week focuses on the enablement requirement. It’s the first case...

Enter TitleFederal Circuit Revisits Standard for Enablement of Antibody Claims

Written by: Ashley C. Morales & Joseph Mallon, Ph.D. In Baxalta Incorporated v. Genentech, Inc., 2022-1461, the Federal Circuit affirmed the district court’s decision...

Fresh From the Bench: Latest Precedential Patent Cases

CASE OF THE WEEK Columbia Sportswear North America, Inc. v. Seirus Innovative Accessories, Inc., Appeal Nos. 2021-2299, -2338 (Fed. Cir. Sept. 15, 2023) In a decade-old case that has ...

Prosecution History May Support a Motivation to Combine

Written by: Rhett D. Ramsey & Jacob R. Rosenbaum Elekta Limited v. Zap Surgical Systems, Inc. Before: Reyna, Stoll, and Stark. Appeal from the Patent Trial and Appeal Board. ...

Landmark CAFC Cases in Patent Law: Shaping the Future of Innovation

In the ever-evolving landscape of patent law, the Court of Appeals for the Federal Circuit (CAFC) has played a pivotal role in shaping the rules and precedents governing intellectual...

Feed tagged as "biotechnology":
FDA Approves Generic Fluorescein Injection
Knobbe Martens 4 days ago
Written by: Alistair J. McIntyre & Jason J. Jardine On September 26, 2023, Nexus Pharmaceuticals, LLC[1] announced[2] that it had... Read More »
Comment: 0 Favorite (0)
Enter TitleFederal Circuit Revisits Standard for Enablement of Antibody Claims
Knobbe Martens 7 days ago
Written by: Ashley C. Morales & Joseph Mallon, Ph.D. In Baxalta Incorporated v. Genentech, Inc., 2022-1461, the Federal Circuit... Read More »
Comment: 0 Favorite (0)
Shire v. Blackburn: Drawing the Line Between FDA Drug Labeling Regulations and State Law on Product Liability
Knobbe Martens Sep 12, 2023
Written by: Ari Feinstein & Jane Dai, Ph.D. On June 2, 2023, drug manufacturer Shire US Inc. and related entity Shire LLC... Read More »
Comment: 0 Favorite (0)
Free Samples and Fillers: No Teaching Away or Commercial Success
Knobbe Martens Aug 24, 2023
Written by: Kenneth McNeill & Daniel P. Hughes INCEPT LLC v. PALETTE LIFE SCIENCES, INC. Before Newman, Schall, and... Read More »
Comment: 0 Favorite (0)
Reseller or Distributer Beware? Downstream Liability for Infringing a Patented Process
Knobbe Martens Jul 11, 2023
Written by: Zachary B. Messick & Brenden S. Gingrich, Ph.D. As retailers or distributors that are not manufacturers of a product... Read More »
Comment: 0 Favorite (0)
Can’t Stop a Bull: Limits of Claim Preclusion
Knobbe Martens Jul 6, 2023
Written by: Cesar A. Estrada & Jeremy Anapol INGURAN, LLC, DBA STGENETICS v. ABS GLOBAL, INC., GENUS PLC Before Lourie... Read More »
Comment: 0 Favorite (0)
Analogous Art Must Be Compared to the Challenged Patent
Knobbe Martens Jun 9, 2023
Written by: Rhett D. Ramsey & Michael L. Fuller In Sanofi-Aventis Deutschland GmbH v. Mylan Pharm. Inc., Case No. 2021-1981, the... Read More »
Comment: 0 Favorite (0)
Merck Sues Federal Government Over Medicare Drug Price Negotiation Program
Knobbe Martens Jun 7, 2023
Written by: Brianne M. Kingery & Eric Furman, Ph.D. On June 6, 2023, Merck & Co. filed a lawsuit against the U.S. government... Read More »
Comment: 0 Favorite (0)
FDA Approves Qalsody™ for Treatment of ALS
Knobbe Martens May 30, 2023
Written by: Douglas W. Crandell, Ph.D. & Robert J. Hilton, Ph.D. On April 25th, 2023, the U.S. Food and Drug Administration (FDA)... Read More »
Comment: 0 Favorite (0)
Recessions and Patent Applications: Navigating the Ups and Downs of the Innovation Economy
Knobbe Martens May 22, 2023
Written by: Sophia Petrichenko & Jason J. Jardine As predictions of an economic recession in the United States loom, 2023 has... Read More »
Comment: 0 Favorite (0)
Implications of the Proposed EU Pharmaceutical Law Reform Overhaul
Knobbe Martens May 10, 2023
Written by:Nima Zargari, Ph.D.  & Joseph Mallon, Ph.D. On April 26, 2023, the European Commission proposed a pharmaceutical law... Read More »
Comment: 0 Favorite (0)
Supreme Court Issues Stay in Mifepristone Case, Preserving Status Quo for Now
Knobbe Martens Apr 28, 2023
Written by: Alistair J. McIntyre & Jane Dai, Ph.D.   On April 21, 2023, the Supreme Court granted a ... Read More »
Comment: 0 Favorite (0)
A Patent for Controlling Access to Drugs Is Not Listable in the Orange Book
Knobbe Martens Apr 14, 2023
Written by: Blake A. Winn & Jason J. Jardine The “Orange Book”, more formally known as Approved Drug Products with... Read More »
Comment: 0 Favorite (0)
Federal Circuit Finds Patent for Dietary Supplements Invalid Under § 101 for Reciting Naturally Occurring Milk Components
Knobbe Martens Apr 14, 2023
Written by: Ashley C. Morales & Michael L. Fuller In ChromaDex, Inc. v Elysium Health, Inc., Appeal No. 2022-1116, the Federal... Read More »
Comment: 0 Favorite (0)
Incorporation by Reference: Patent Portfolio Builder or Destroyer?
Knobbe Martens Apr 12, 2023
Written by: Zachary B. Messick & Douglas B. Wentzel ARBUTUS BIOPHARMA CORPORATION v. MODERNATX, INC. Before Reyna, Schall, ... Read More »
Comment: 0 Favorite (0)
Teva v. GSK: The “Skinny” Label Case Pending Before the Supreme Court
Knobbe Martens Apr 10, 2023
Written by: Ari Feinstein & Agnes Juang, Ph.D. On March 29, 2023, the Solicitor General of the United States asked the Supreme... Read More »
Comment: 0 Favorite (0)
Description Prescription
Knobbe Martens Mar 6, 2023
Written by: Brandon D. Hupka & Hans L. Mayer REGENTS OF THE UNIVERSITY OF MINNESOTA V. GILEAD SCIENCES, INC. Before... Read More »
Comment: 0 Favorite (0)
BioNTech to Ship Modular mRNA Vaccine Factory to Rwanda
Knobbe Martens Jan 23, 2023
Written by: Mark Rubinshtein, Ph.D. Biopharmaceutical New Technologies (BioNTech), the global immunotherapy company based in... Read More »
Comment: 0 Favorite (0)
Pfizer and BioNTech Strike Back to CureVac's Lawsuit by Seeking Declaratory Judgment of Noninfringement | Who Will Control mRNA Tech?
Mikele Bicolli Aug 28, 2022
Two days ago, the companies that joined forces in order to develop the first Covid vaccine that got approval for emergency use by FDA... Read More »
Comment: 0 Favorite (0)
Expert Testimony That Contradicts Patent Specification Fails to Create a Genuine Issue of Fact in a Patent Eligibility Dispute
Knobbe Martens Jul 21, 2022
CAREDX, INC. V. NATERA, INC. Before Lourie, Bryson, and Hughes Summary: Expert testimony that steps of challenged patent claims... Read More »
Comment: 0 Favorite (0)
Show more Newsfeed posts
Menu